Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature.
Nephrogenic systemic fibrosis (NSF) is a systemic fibrosing disorder which has been strongly associated with exposure to gadolinium-based contrast media (GBCM) in the setting of renal insufficiency. Although this disorder primarily affects the skin, it can result in severe joint contractures, disabilities and even death. However, to date, there have been no published studies reporting chronic imaging findings of NSF. In this report we present three biopsy-proven cases of NSF with the associated chronic MRI, radiographic and bone scintigraphy findings. Two of the patients had been exposed to gadodiamide, and one had been exposed to gadopentetate dimeglumine prior to the onset of NSF. Two are newly reported cases. One patient's subacute imaging findings have previously been reported, but significant chronic images will now be presented. This patient became severely disabled from contractures and developed long bone smooth periosteal reaction, extensive intra-articular and periarticular calcifications, musculotendinous heterotopic ossification and ankylosis of several joints. One of the patients underwent renal transplantation 6 months after GBCM exposure, with near complete resolution of the skin fibrosis. The third patient had persistent MRI findings of skin thickening, with low T1 and high T2 signal intensity 5 years after exposure to gadodiamide. A review of the medical literature is provided, emphasizing the association of NSF with various GBCM. These cases broaden our understanding of the long-term imaging findings and complications of NSF and the stratified risk of NSF with various GBCM.
Weigle
Jeffrey P
JP
Department of Radiology, Loma Linda University Medical Center, 11234 Anderson St., Room 2606, Loma Linda, CA 92354, USA.
Broome
Dale R
DR
D000328:Adult; D003287:Contrast Media / Q000009:adverse effects; D005260:Female; D005355:Fibrosis / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D019786:Gadolinium DTPA / Q000009:adverse effects; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000473:pathology; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D008297:Male; D009140:Musculoskeletal Diseases / Q000175:diagnosis* / Q000209:etiology* / Q000628:therapy
D003287:Contrast Media; C064925:gadodiamide; D019786:Gadolinium DTPA